Table 2:
Serum markers | PHC (n=1075) | Cirrhosis (n=237) | Control (n=50) |
---|---|---|---|
AFP | 681(63.35) | 53(22.3) | 2(4) |
AFP+CEA | 83(7.7) | 6(2.5) | 1(2) |
AFP+CA19-9 | 78(7.3) | 15(6.8) | 1(2) |
AFP+CEA+CA19-9 | 27(2.5) | 0(0) | 0(0) |
n=Number of positive cases
Serum markers | PHC (n=1075) | Cirrhosis (n=237) | Control (n=50) |
---|---|---|---|
AFP | 681(63.35) | 53(22.3) | 2(4) |
AFP+CEA | 83(7.7) | 6(2.5) | 1(2) |
AFP+CA19-9 | 78(7.3) | 15(6.8) | 1(2) |
AFP+CEA+CA19-9 | 27(2.5) | 0(0) | 0(0) |
n=Number of positive cases